Search research articles
Contact Us
Filters
Showing results (51-60 of 78) with videos related to
Page
of 8
Sort By:
Blood Advances
|
August 22, 2025
Frail subgroups determine heterogeneous outcomes in older patients with NDMM - long-term follow-up of the HOVON 143 trial
Febe Smits, Kaz Groen, Mark-David Levin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 4, 2021
Ixazomib, Daratumumab, and Low-Dose Dexamethasone in Frail Patients With Newly Diagnosed Multiple Myeloma: The Hovon 143 Study
Claudia A M Stege, Kazem Nasserinejad, Ellen van der Spek, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 15, 2024
Doxorubicin Exposure and Breast Cancer Risk in Survivors of Adolescent and Adult Hodgkin Lymphoma
Suzanne I M Neppelenbroek, Yvonne M Geurts, Berthe M P Aleman, et al.
Haematologica
|
December 1, 2020
Treatment of patients with MYC rearrangement positive large B-cell lymphoma with R-CHOP plus lenalidomide: results of a multicenter HOVON phase II trial
Martine E D Chamuleau, Coreline N Burggraaff, Marcel Nijland, et al.
Hemasphere
|
October 31, 2022
Improved Clinical Outcome of COVID-19 in Hematologic Malignancy Patients Receiving a Fourth Dose of Anti-SARS-CoV-2 Vaccine: An EPICOVIDEHA Report
Jon Salmanton-García, Francesco Marchesi, Andreas Glenthøj, et al.
Blood
|
November 8, 2021
COVID-19 in vaccinated adult patients with hematological malignancies: preliminary results from EPICOVIDEHA
Livio Pagano, Jon Salmanton-García, Francesco Marchesi, et al.
ESMO Open
|
February 13, 2024
Treatment-specific risk of subsequent malignant neoplasms in five-year survivors of diffuse large B-cell lymphoma
Y M Geurts, S I M Neppelenbroek, B M P Aleman, et al.
Leukemia
|
February 16, 2021
Improving the identification of frail elderly newly diagnosed multiple myeloma patients
Claudia A M Stege, Kazem Nasserinejad, Saskia K Klein, et al.
Journal of Hematology & Oncology
|
April 3, 2023
Passive pre-exposure immunization by tixagevimab/cilgavimab in patients with hematological malignancy and COVID-19: matched-paired analysis in the EPICOVIDEHA registry
Francesco Marchesi, Jon Salmanton-García, Caterina Buquicchio, et al.
Blood Advances
|
May 2, 2022
COVID-19 and hairy-cell leukemia: an EPICOVIDEHA survey
Sylvain Lamure, Jon Salmanton-García, Elena Robin-Marieton, et al.
Page
of 8
Search research articles
Search
Showing results (51-60 of 78) with videos related to
Sort By:
Page
of 8
Blood Advances
|
August 22, 2025
Frail subgroups determine heterogeneous outcomes in older patients with NDMM - long-term follow-up of the HOVON 143 trial
Febe Smits, Kaz Groen, Mark-David Levin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 4, 2021
Ixazomib, Daratumumab, and Low-Dose Dexamethasone in Frail Patients With Newly Diagnosed Multiple Myeloma: The Hovon 143 Study
Claudia A M Stege, Kazem Nasserinejad, Ellen van der Spek, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 15, 2024
Doxorubicin Exposure and Breast Cancer Risk in Survivors of Adolescent and Adult Hodgkin Lymphoma
Suzanne I M Neppelenbroek, Yvonne M Geurts, Berthe M P Aleman, et al.
Haematologica
|
December 1, 2020
Treatment of patients with MYC rearrangement positive large B-cell lymphoma with R-CHOP plus lenalidomide: results of a multicenter HOVON phase II trial
Martine E D Chamuleau, Coreline N Burggraaff, Marcel Nijland, et al.
Hemasphere
|
October 31, 2022
Improved Clinical Outcome of COVID-19 in Hematologic Malignancy Patients Receiving a Fourth Dose of Anti-SARS-CoV-2 Vaccine: An EPICOVIDEHA Report
Jon Salmanton-García, Francesco Marchesi, Andreas Glenthøj, et al.
Blood
|
November 8, 2021
COVID-19 in vaccinated adult patients with hematological malignancies: preliminary results from EPICOVIDEHA
Livio Pagano, Jon Salmanton-García, Francesco Marchesi, et al.
ESMO Open
|
February 13, 2024
Treatment-specific risk of subsequent malignant neoplasms in five-year survivors of diffuse large B-cell lymphoma
Y M Geurts, S I M Neppelenbroek, B M P Aleman, et al.
Leukemia
|
February 16, 2021
Improving the identification of frail elderly newly diagnosed multiple myeloma patients
Claudia A M Stege, Kazem Nasserinejad, Saskia K Klein, et al.
Journal of Hematology & Oncology
|
April 3, 2023
Passive pre-exposure immunization by tixagevimab/cilgavimab in patients with hematological malignancy and COVID-19: matched-paired analysis in the EPICOVIDEHA registry
Francesco Marchesi, Jon Salmanton-García, Caterina Buquicchio, et al.
Blood Advances
|
May 2, 2022
COVID-19 and hairy-cell leukemia: an EPICOVIDEHA survey
Sylvain Lamure, Jon Salmanton-García, Elena Robin-Marieton, et al.
Page
of 8